
Accumulating results from studies investigating a light-adjustable IOL indicate this technology can afford precise postoperative control over refractive outcomes

Accumulating results from studies investigating a light-adjustable IOL indicate this technology can afford precise postoperative control over refractive outcomes

A monofocal hydrophilic acrylic IOL with a square-edge design has high capsular biocompatibility

Ad advanced LASIK procedure provides excellent visual outcomes, night vision, and overall quality of vision.

Accurate biometry, accurate keratometry, use of both an appropriate IOL power calculation formula and personalized A-constant, and the elimination of astigmatism all are essential factors for obtaining a good refractive result following cataract surgery in eyes with a history of keratorefractive surgery.

For me, 2009 will go down as a year of disappointment.

An angle-supported phakic lens had a minimal effect on corneal endothelial cell health in patients followed up to 4 years after implantation.

Wavefront-optimized PRK performed off-label with a 400-Hz excimer laser produced excellent safety and visual outcomes.

Comparing a refractive multifocal IOL with a diffractive multifocal IOL showed that the diffractive multifocal lens provides excellent intermediate visual acuity despite theoretical predictions to the contrary.

Although Descemet's membrane endothelial keratoplasty represents the ideal of pure anatomic replacement surgery, results of a laboratory study indicate the procedure is still in an early stage of development.

Many men Dr. McDonnell's age become attached to certain items of clothing.

The past year saw a continuation of developments and refinements of refractive surgery technologies.

When Joseph J. Sokol, MD, decided to break out on his own about a year ago, one of his first major decisions was choosing an electronic medical record company.

Society will remember Charles Kelman, MD, for his many accomplishments.

It's the time of year when optical chain executives take time to review their company's performance and revise the strategic plan.

This has been a year filled with many exciting developments in cataract surgery.

Marketing the right accessories and getting a little creative with displays is a sure way to boost profit in your office.

The Jakarta, Indonesia, ophthalmic lens manufacturing plant of Vision-Ease Lens (VEL) sustained damage from a major fire in November.

NeoVista Inc.'s new epimacular brachytherapy system (Vidion Anti-Neovascular Surgical System) for the treatment of age-related macular degeneration is now available in the United Kingdom

In an effort to increase patient adherence to therapy and safety, as well as to maximize effectiveness, two eye-health products (Macular Health Formula and Dry Eye Formula, EyeScience) are sold to both eye-care professionals for resale from their offices and through a mass market retailer.

Manus C. Kraff, MD, of Chicago is the 2009 recipient of the American Medical Association (AMA) Benjamin Rush Award for Citizenship and Community Service.

OD-OS has received FDA 510(k) clearance and CE mark approval for its recently released navigated retina laser therapy system (Navilas).

The FDA has reopened a public docket to receive information and comments about LASIK devices, it was reported in the Nov. 13 Federal Register. The agency will accept remarks until Nov. 15, 2010.

The Centers for Medicare and Medicaid Services has stopped recognizing code Q2024 to pay for the office-based ophthalmic use of bevacizumab (Avastin, Genentech).

An investigational telescope implant has been given an 8-0 approvable vote by the FDA advisory panel.

As attendees gather for the Wilmer Eye Institute's 22nd annual Current Concepts in Ophthalmology meeting, they can expect the agenda to focus on clinical use and medical issues important to ophthalmology.

The retail optical industry is down 2.5% in 2009, according to industry published data.

If you don't know the question you want to ask, you can't ask the question to get the information you need to stay out of trouble.

When performing cataract surgery, it is critical to understand the properties of ophthalmic and viscosurgical devices.

A key role of ARVO in the eye and vision research community is to recognize excellence.

To a busy ophthalmologist, time is a valuable commodity, and with proposed Mediare cuts looming, it is a daily focus and concern.